Predicting outcomes in HIV-infected veterans: I. Progression to AIDS

Journal of Clinical Epidemiology

Volumn 50, Issue 11, 1997, Pages 1231-1240

  Rabeneck, Linda ^a,c   Hartigan, Pamela M ^b   Huang, Iris W ^a   Souchek, Julianne ^a   Wray, Nelda P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Dept Vet Aff Coop Studs Prog ^*  (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; HIV; Prognosis; Severity of illness index

Indexed keywords

CD4 ANTIGEN; HEMOGLOBIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STAGING; THRUSH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MARKOV CHAINS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VETERANS; ZIDOVUDINE;

EID: 0030728170     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00181-9     Document Type: Article

References (24)

1. Feinstein AR. Clinical biostatistics. XIV. The purposes of prognostic stratification. Clin Pharmacol Ther 1972; 13: 285-297.
2. Feinstein AR. Clinical Epidemiology. The Architecture of Clinical Research. Philadelphia: WB Saunders; 1985.
3. Rabeneck L, Wray NP. Predicting the outcomes of human immunodeficiency virus infection: How well are we doing? Arch Intern Med 1993; 153: 2749-2755.
4. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-17): 1-19.
5. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med 1986; 314: 131-132.
6. MacDonell KB, Chmiel JS, Goldsmith J, et al. Prognostic usefulness of the Walter Reed staging classification for HIV infection. J Acquir Immune Dene Syndr 1988; 1: 367-374.
7. Royce RA, Luckmann RS, Fusaro RE, et al. The natural history of HIV-1 infection: Staging classifications of disease. AIDS 1991; 5: 355-364.
8. Rabeneck L, Hartigan PM, Huang IW, et al. Predicting outcomes in HIV-infected veterans: II. Survival after AIDS. J Clin Epidemiol 1997; 50(11): 1241-1248.
9. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 1-15S.
10. Hamilton JD, Hartigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. N Engl J Med 1992; 326: 437-443.
11. Simberkoff MS, Hartigan PM, Hamilton JD, et al. Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment: Report of a Veterans Affairs Cooperative Study. J Acquir Immune Defic Syndr 1996; 11: 142-150.
12. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley & Sons; 1980.
13. Chow WK. A Look at Various Estimators in Logistic Models in the Presence of Missing Values. Santa Monica: Rand; 1979.
14. Weingarten S, Bolus R, Riedinger MS, et al. The principle of parsimony: Glasgow coma scale score predicts mortality as well as the APACHE II score for stroke patients. Stroke 1990; 21: 1280-1282.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481.
16. Efron B. The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia: SIAM; 1982.
17. Chiang CL. An Introduction to Stochastic Processes and Their Applications, 2nd Edition. New York: Krieger; 1980.
18. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, Ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949: 191-205.
19. CDC. HIV/AIDS Surveillance Report. Atlanta: U.S. Department of Health and Human Services, Public Health Service 1996; 8: 1-33.
20. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. JAMA 1996; 276: 146-154.
21. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-1170.
22. Rabeneck L, Crane MM, Risser JMH, et al. A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats. J Gen Intern Med 1993; 8: 5-9.
23. Rabeneck L, Hartigan PM, Huang IW, Souchek J, Wray NP. Predicting progression to AIDS: An evaluation of two approaches. J Gen Intern Med 1996; 11: 622-624.
24. Roberts J. HIV in plasma is best predictor of progression to AIDS. BMJ 1996; 312: 1437-1438. (Editorial)